95 related articles for article (PubMed ID: 8259152)
1. Vesnarinone for heart failure.
Neely D
N Engl J Med; 1994 Jan; 330(1):65. PubMed ID: 8259152
[No Abstract] [Full Text] [Related]
2. Severe heart failure: balancing length and quality of life.
Harv Heart Lett; 1999 Jun; 9(10):1-2. PubMed ID: 10233785
[No Abstract] [Full Text] [Related]
3. Vesnarinone for heart failure.
Swedberg K; Wedel H
N Engl J Med; 1994 Jan; 330(1):64; author reply 65. PubMed ID: 8259151
[No Abstract] [Full Text] [Related]
4. Vesnarinone for heart failure.
Schwartz A; Grupp I; Grupp G
N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153
[No Abstract] [Full Text] [Related]
5. Inotropic therapy for heart failure.
Stevenson LW
N Engl J Med; 1998 Dec; 339(25):1848-50. PubMed ID: 9854124
[No Abstract] [Full Text] [Related]
6. [Usefulness of OPC-8212, an inotropic agent, in patients with chronic congestive heart failure--a multiple dose evaluation on its effect and arrhythmogenesis].
Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
Kokyu To Junkan; 1988 Oct; 36(10):1125-31. PubMed ID: 3247528
[No Abstract] [Full Text] [Related]
7. Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
LeJemtel TH
Curr Cardiol Rep; 1999 May; 1(1):31. PubMed ID: 10980817
[No Abstract] [Full Text] [Related]
8. Chronic heart failure and the quality of life.
Pritzker MR
N Engl J Med; 1999 May; 340(19):1511; author reply 1512. PubMed ID: 10328720
[No Abstract] [Full Text] [Related]
9. Positive inotropic agents: a double-edged sword for chronic heart failure.
Asanoi H; Inoue H
Intern Med; 1996 Jan; 35(1):63-4. PubMed ID: 8652942
[No Abstract] [Full Text] [Related]
10. The search for the ideal positive inotropic agent.
Packer M
N Engl J Med; 1993 Jul; 329(3):201-2. PubMed ID: 8515793
[No Abstract] [Full Text] [Related]
11. [Challenge for the general practitioner. Sufficient therapy for heart failure].
Füessl HS
MMW Fortschr Med; 2000 Nov; 142(46):4-8. PubMed ID: 11132311
[No Abstract] [Full Text] [Related]
12. Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group.
Soran O; Young JD; Holubkov R; Loftus S; Bourge R; Carson P; Jaski B; White BG; Feldman AM
J Card Fail; 1999 Sep; 5(3):195-200; discussion 201-2. PubMed ID: 10496192
[TBL] [Abstract][Full Text] [Related]
13. Effects of pitavastin in Japanese patients with chronic heart failure.
D'Imperio H; Sanchis J; Núñez E; Núñez J
Circ J; 2013; 77(8):2204. PubMed ID: 23759657
[No Abstract] [Full Text] [Related]
14. Effects of pitavastatin in Japanese patients with chronic heart failure. Reply.
Takano H
Circ J; 2013; 77(8):2205. PubMed ID: 23759658
[No Abstract] [Full Text] [Related]
15. Statin therapy in chronic heart failure: frog prince or bare frog?
Kihara Y
Circ J; 2013; 77(4):895-7. PubMed ID: 23502989
[No Abstract] [Full Text] [Related]
16. Chronic heart failure and the quality of life.
Alhaddad IA
N Engl J Med; 1999 May; 340(19):1511-2. PubMed ID: 10328721
[No Abstract] [Full Text] [Related]
17. Intravenous amrinone for congestive heart failure.
Med Lett Drugs Ther; 1984 Nov; 26(675):104-5. PubMed ID: 6390109
[No Abstract] [Full Text] [Related]
18. [Lower digitalis dosage in heart failure].
Madsen S; Holene E
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1053-4. PubMed ID: 17457392
[No Abstract] [Full Text] [Related]
19. Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard?
Krum H; Cameron P
J Card Fail; 2006 Jun; 12(5):333-5. PubMed ID: 16762793
[No Abstract] [Full Text] [Related]
20. Digoxin for the treatment of heart failure.
Hallberg P; Michaëlsson K; Melhus H
N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
